Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy.
Identifieur interne : 000769 ( PubMed/Curation ); précédent : 000768; suivant : 000770Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy.
Auteurs : Michael Leonardi [États-Unis] ; Thomas Latiolais [États-Unis] ; Kwabena Sarpong [États-Unis] ; Michael Simon [États-Unis] ; Jerry Twiggs [États-Unis] ; Paul Lei [États-Unis] ; Stephen Rinderknecht [États-Unis] ; Mark Blatter [États-Unis] ; Veronique Bianco [Belgique] ; Yaela Baine [États-Unis] ; Leonard R. Friedland [États-Unis] ; Jacqueline M. Miller [États-Unis]Source :
- Vaccine [ 1873-2518 ] ; 2015.
Descripteurs français
- KwdFr :
- Anatoxine tétanique (administration et posologie), Anatoxine tétanique (immunologie), Calendrier d'administration des médicaments, Femelle, Humains, Mâle, Nourrisson, Vaccins anti-Haemophilus (administration et posologie), Vaccins anti-Haemophilus (immunologie), Vaccins antiméningococciques (administration et posologie), Vaccins antiméningococciques (immunologie), Vaccins conjugués (administration et posologie), Vaccins conjugués (immunologie).
- MESH :
- administration et posologie : Anatoxine tétanique, Vaccins anti-Haemophilus, Vaccins antiméningococciques, Vaccins conjugués.
- immunologie : Anatoxine tétanique, Vaccins anti-Haemophilus, Vaccins antiméningococciques, Vaccins conjugués.
- Calendrier d'administration des médicaments, Femelle, Humains, Mâle, Nourrisson.
English descriptors
- KwdEn :
- Drug Administration Schedule, Female, Haemophilus Vaccines (administration & dosage), Haemophilus Vaccines (immunology), Humans, Infant, Male, Meningococcal Vaccines (administration & dosage), Meningococcal Vaccines (immunology), Tetanus Toxoid (administration & dosage), Tetanus Toxoid (immunology), Vaccines, Conjugate (administration & dosage), Vaccines, Conjugate (immunology).
- MESH :
- chemical , administration & dosage : Haemophilus Vaccines, Meningococcal Vaccines, Tetanus Toxoid, Vaccines, Conjugate.
- chemical , immunology : Haemophilus Vaccines, Meningococcal Vaccines, Tetanus Toxoid, Vaccines, Conjugate.
- Drug Administration Schedule, Female, Humans, Infant, Male.
Abstract
Immunogenicity and safety of a single dose of MenACWY-TT or a fourth dose of HibMenCY-TT were evaluated in the second year of life in HibMenCY-TT-primed toddlers.
DOI: 10.1016/j.vaccine.2014.08.027
PubMed: 25152325
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000769
Links to Exploration step
pubmed:25152325Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy.</title><author><name sortKey="Leonardi, Michael" sort="Leonardi, Michael" uniqKey="Leonardi M" first="Michael" last="Leonardi">Michael Leonardi</name><affiliation wicri:level="1"><nlm:affiliation>Palmetto Pediatrics, 2781 Tricom St, North Charleston, SC 29406, United States. Electronic address: mikeyleonardi@yahoo.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Palmetto Pediatrics, 2781 Tricom St, North Charleston, SC 29406</wicri:regionArea></affiliation></author><author><name sortKey="Latiolais, Thomas" sort="Latiolais, Thomas" uniqKey="Latiolais T" first="Thomas" last="Latiolais">Thomas Latiolais</name><affiliation wicri:level="1"><nlm:affiliation>ACC Pediatric Research, Oak Thicket Shopping Center, 1025 Highway 80 East Haughton, Bossier City, LA 71037, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>ACC Pediatric Research, Oak Thicket Shopping Center, 1025 Highway 80 East Haughton, Bossier City, LA 71037</wicri:regionArea></affiliation></author><author><name sortKey="Sarpong, Kwabena" sort="Sarpong, Kwabena" uniqKey="Sarpong K" first="Kwabena" last="Sarpong">Kwabena Sarpong</name><affiliation wicri:level="1"><nlm:affiliation>Division of General Academic Pediatrics, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of General Academic Pediatrics, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555</wicri:regionArea></affiliation></author><author><name sortKey="Simon, Michael" sort="Simon, Michael" uniqKey="Simon M" first="Michael" last="Simon">Michael Simon</name><affiliation wicri:level="1"><nlm:affiliation>Baptist Health Lexington, 1740 Nicholasville Road, Lexington, KY 40503, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Baptist Health Lexington, 1740 Nicholasville Road, Lexington, KY 40503</wicri:regionArea></affiliation></author><author><name sortKey="Twiggs, Jerry" sort="Twiggs, Jerry" uniqKey="Twiggs J" first="Jerry" last="Twiggs">Jerry Twiggs</name><affiliation wicri:level="1"><nlm:affiliation>Dixie Pediatrics, 1240 E 100 S Suite 14, Saint George, UT 84790, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Dixie Pediatrics, 1240 E 100 S Suite 14, Saint George, UT 84790</wicri:regionArea></affiliation></author><author><name sortKey="Lei, Paul" sort="Lei, Paul" uniqKey="Lei P" first="Paul" last="Lei">Paul Lei</name><affiliation wicri:level="1"><nlm:affiliation>Jordan Valley Medical Center, 3580 West 9000 South, West Jordan, UT 84088, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Jordan Valley Medical Center, 3580 West 9000 South, West Jordan, UT 84088</wicri:regionArea></affiliation></author><author><name sortKey="Rinderknecht, Stephen" sort="Rinderknecht, Stephen" uniqKey="Rinderknecht S" first="Stephen" last="Rinderknecht">Stephen Rinderknecht</name><affiliation wicri:level="1"><nlm:affiliation>30 E Hickman Road, Waukee, IA 50263, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>30 E Hickman Road, Waukee, IA 50263</wicri:regionArea></affiliation></author><author><name sortKey="Blatter, Mark" sort="Blatter, Mark" uniqKey="Blatter M" first="Mark" last="Blatter">Mark Blatter</name><affiliation wicri:level="1"><nlm:affiliation>Saint Clair Hospital, 1000 Bower Hill Road, Pittsburgh, PA 15243, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Saint Clair Hospital, 1000 Bower Hill Road, Pittsburgh, PA 15243</wicri:regionArea></affiliation></author><author><name sortKey="Bianco, Veronique" sort="Bianco, Veronique" uniqKey="Bianco V" first="Veronique" last="Bianco">Veronique Bianco</name><affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Vaccines, Rue Fleming 20, Wavre 1300, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>GlaxoSmithKline Vaccines, Rue Fleming 20, Wavre 1300</wicri:regionArea></affiliation></author><author><name sortKey="Baine, Yaela" sort="Baine, Yaela" uniqKey="Baine Y" first="Yaela" last="Baine">Yaela Baine</name><affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406</wicri:regionArea></affiliation></author><author><name sortKey="Friedland, Leonard R" sort="Friedland, Leonard R" uniqKey="Friedland L" first="Leonard R" last="Friedland">Leonard R. Friedland</name><affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406</wicri:regionArea></affiliation></author><author><name sortKey="Miller, Jacqueline M" sort="Miller, Jacqueline M" uniqKey="Miller J" first="Jacqueline M" last="Miller">Jacqueline M. Miller</name><affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25152325</idno><idno type="pmid">25152325</idno><idno type="doi">10.1016/j.vaccine.2014.08.027</idno><idno type="wicri:Area/PubMed/Corpus">000769</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000769</idno><idno type="wicri:Area/PubMed/Curation">000769</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000769</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy.</title><author><name sortKey="Leonardi, Michael" sort="Leonardi, Michael" uniqKey="Leonardi M" first="Michael" last="Leonardi">Michael Leonardi</name><affiliation wicri:level="1"><nlm:affiliation>Palmetto Pediatrics, 2781 Tricom St, North Charleston, SC 29406, United States. Electronic address: mikeyleonardi@yahoo.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Palmetto Pediatrics, 2781 Tricom St, North Charleston, SC 29406</wicri:regionArea></affiliation></author><author><name sortKey="Latiolais, Thomas" sort="Latiolais, Thomas" uniqKey="Latiolais T" first="Thomas" last="Latiolais">Thomas Latiolais</name><affiliation wicri:level="1"><nlm:affiliation>ACC Pediatric Research, Oak Thicket Shopping Center, 1025 Highway 80 East Haughton, Bossier City, LA 71037, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>ACC Pediatric Research, Oak Thicket Shopping Center, 1025 Highway 80 East Haughton, Bossier City, LA 71037</wicri:regionArea></affiliation></author><author><name sortKey="Sarpong, Kwabena" sort="Sarpong, Kwabena" uniqKey="Sarpong K" first="Kwabena" last="Sarpong">Kwabena Sarpong</name><affiliation wicri:level="1"><nlm:affiliation>Division of General Academic Pediatrics, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of General Academic Pediatrics, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555</wicri:regionArea></affiliation></author><author><name sortKey="Simon, Michael" sort="Simon, Michael" uniqKey="Simon M" first="Michael" last="Simon">Michael Simon</name><affiliation wicri:level="1"><nlm:affiliation>Baptist Health Lexington, 1740 Nicholasville Road, Lexington, KY 40503, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Baptist Health Lexington, 1740 Nicholasville Road, Lexington, KY 40503</wicri:regionArea></affiliation></author><author><name sortKey="Twiggs, Jerry" sort="Twiggs, Jerry" uniqKey="Twiggs J" first="Jerry" last="Twiggs">Jerry Twiggs</name><affiliation wicri:level="1"><nlm:affiliation>Dixie Pediatrics, 1240 E 100 S Suite 14, Saint George, UT 84790, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Dixie Pediatrics, 1240 E 100 S Suite 14, Saint George, UT 84790</wicri:regionArea></affiliation></author><author><name sortKey="Lei, Paul" sort="Lei, Paul" uniqKey="Lei P" first="Paul" last="Lei">Paul Lei</name><affiliation wicri:level="1"><nlm:affiliation>Jordan Valley Medical Center, 3580 West 9000 South, West Jordan, UT 84088, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Jordan Valley Medical Center, 3580 West 9000 South, West Jordan, UT 84088</wicri:regionArea></affiliation></author><author><name sortKey="Rinderknecht, Stephen" sort="Rinderknecht, Stephen" uniqKey="Rinderknecht S" first="Stephen" last="Rinderknecht">Stephen Rinderknecht</name><affiliation wicri:level="1"><nlm:affiliation>30 E Hickman Road, Waukee, IA 50263, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>30 E Hickman Road, Waukee, IA 50263</wicri:regionArea></affiliation></author><author><name sortKey="Blatter, Mark" sort="Blatter, Mark" uniqKey="Blatter M" first="Mark" last="Blatter">Mark Blatter</name><affiliation wicri:level="1"><nlm:affiliation>Saint Clair Hospital, 1000 Bower Hill Road, Pittsburgh, PA 15243, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Saint Clair Hospital, 1000 Bower Hill Road, Pittsburgh, PA 15243</wicri:regionArea></affiliation></author><author><name sortKey="Bianco, Veronique" sort="Bianco, Veronique" uniqKey="Bianco V" first="Veronique" last="Bianco">Veronique Bianco</name><affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Vaccines, Rue Fleming 20, Wavre 1300, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>GlaxoSmithKline Vaccines, Rue Fleming 20, Wavre 1300</wicri:regionArea></affiliation></author><author><name sortKey="Baine, Yaela" sort="Baine, Yaela" uniqKey="Baine Y" first="Yaela" last="Baine">Yaela Baine</name><affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406</wicri:regionArea></affiliation></author><author><name sortKey="Friedland, Leonard R" sort="Friedland, Leonard R" uniqKey="Friedland L" first="Leonard R" last="Friedland">Leonard R. Friedland</name><affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406</wicri:regionArea></affiliation></author><author><name sortKey="Miller, Jacqueline M" sort="Miller, Jacqueline M" uniqKey="Miller J" first="Jacqueline M" last="Miller">Jacqueline M. Miller</name><affiliation wicri:level="1"><nlm:affiliation>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406</wicri:regionArea></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Drug Administration Schedule</term><term>Female</term><term>Haemophilus Vaccines (administration & dosage)</term><term>Haemophilus Vaccines (immunology)</term><term>Humans</term><term>Infant</term><term>Male</term><term>Meningococcal Vaccines (administration & dosage)</term><term>Meningococcal Vaccines (immunology)</term><term>Tetanus Toxoid (administration & dosage)</term><term>Tetanus Toxoid (immunology)</term><term>Vaccines, Conjugate (administration & dosage)</term><term>Vaccines, Conjugate (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anatoxine tétanique (administration et posologie)</term><term>Anatoxine tétanique (immunologie)</term><term>Calendrier d'administration des médicaments</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Nourrisson</term><term>Vaccins anti-Haemophilus (administration et posologie)</term><term>Vaccins anti-Haemophilus (immunologie)</term><term>Vaccins antiméningococciques (administration et posologie)</term><term>Vaccins antiméningococciques (immunologie)</term><term>Vaccins conjugués (administration et posologie)</term><term>Vaccins conjugués (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Haemophilus Vaccines</term><term>Meningococcal Vaccines</term><term>Tetanus Toxoid</term><term>Vaccines, Conjugate</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Haemophilus Vaccines</term><term>Meningococcal Vaccines</term><term>Tetanus Toxoid</term><term>Vaccines, Conjugate</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anatoxine tétanique</term><term>Vaccins anti-Haemophilus</term><term>Vaccins antiméningococciques</term><term>Vaccins conjugués</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anatoxine tétanique</term><term>Vaccins anti-Haemophilus</term><term>Vaccins antiméningococciques</term><term>Vaccins conjugués</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Administration Schedule</term><term>Female</term><term>Humans</term><term>Infant</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Calendrier d'administration des médicaments</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Nourrisson</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Immunogenicity and safety of a single dose of MenACWY-TT or a fourth dose of HibMenCY-TT were evaluated in the second year of life in HibMenCY-TT-primed toddlers.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25152325</PMID><DateCreated><Year>2015</Year><Month>01</Month><Day>31</Day></DateCreated><DateCompleted><Year>2015</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2015</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>7</Issue><PubDate><Year>2015</Year><Month>Feb</Month><Day>11</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy.</ArticleTitle><Pagination><MedlinePgn>933-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2014.08.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(14)01140-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Immunogenicity and safety of a single dose of MenACWY-TT or a fourth dose of HibMenCY-TT were evaluated in the second year of life in HibMenCY-TT-primed toddlers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Healthy infants were randomized (5:1) and primed at 2, 4 and 6 months of age with HibMenCY-TT and diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus (DTaP-HBV-IPV) vaccine; or Hib-TT and DTaP-HBV-IPV (control). Recipients of HibMenCY-TT+DTaP-HBV-IPV were re-randomized (2:2:1) to receive MenACWY-TT at 12-15 months and DTaP at 15-18 months; MenACWY-TT co-administered with DTaP at 15-18 months; or HibMenCY-TT at 12-15 months and DTaP at 15-18 months. Controls received DTaP only at 15-18 months due to Hib conjugate vaccine shortage. Serum bactericidal activity using human complement (hSBA) and safety were assessed one month after meningococcal vaccination.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After vaccination with MenACWY-TT at 12-15 months or MenACWY-TT+DTaP at 15-18 months, all subjects previously primed for serogroups C/Y had hSBA ≥1:8 for these serogroups. At least 96.1% also had hSBA ≥1:8 for serogroups A/W. All subjects in the HibMenCY-TT group had hSBA ≥1:8 for serogroups C/Y. All pre-defined statistical criteria for meningococcal immunogenicity were satisfied. All vaccination regimens had acceptable safety profiles.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Children primed with three doses of HibMenCY-TT who then received a single dose of MenACWY-TT or a fourth dose of HibMenCY-TT had robust increases in hSBA titers for serogroups C/Y. These data provide support that MenACWY-TT, given with or without the fourth scheduled dose of DTaP could be administered as an alternative to a fourth dose of HibMenCY-TT in the second year of life. This study (110870/110871) is registered at www.clinicaltrials.gov NCT00614614.</AbstractText><CopyrightInformation>Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leonardi</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Palmetto Pediatrics, 2781 Tricom St, North Charleston, SC 29406, United States. Electronic address: mikeyleonardi@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latiolais</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>ACC Pediatric Research, Oak Thicket Shopping Center, 1025 Highway 80 East Haughton, Bossier City, LA 71037, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarpong</LastName><ForeName>Kwabena</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of General Academic Pediatrics, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Baptist Health Lexington, 1740 Nicholasville Road, Lexington, KY 40503, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Twiggs</LastName><ForeName>Jerry</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Dixie Pediatrics, 1240 E 100 S Suite 14, Saint George, UT 84790, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Jordan Valley Medical Center, 3580 West 9000 South, West Jordan, UT 84088, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinderknecht</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>30 E Hickman Road, Waukee, IA 50263, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blatter</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Saint Clair Hospital, 1000 Bower Hill Road, Pittsburgh, PA 15243, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianco</LastName><ForeName>Veronique</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline Vaccines, Rue Fleming 20, Wavre 1300, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baine</LastName><ForeName>Yaela</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedland</LastName><ForeName>Leonard R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Jacqueline M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>GlaxoSmithKline Vaccines, 2301 Renaissance Blvd, RN0220, King of Prussia, PA 19406, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00614614</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018073">Haemophilus Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C527605">Hib-MenCY-TT vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022401">Meningococcal Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013745">Tetanus Toxoid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018074">Vaccines, Conjugate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C576777">tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018073" MajorTopicYN="N">Haemophilus Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022401" MajorTopicYN="N">Meningococcal Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013745" MajorTopicYN="N">Tetanus Toxoid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018074" MajorTopicYN="N">Vaccines, Conjugate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACWY</Keyword><Keyword MajorTopicYN="N">Conjugate vaccine</Keyword><Keyword MajorTopicYN="N">HibMenCY</Keyword><Keyword MajorTopicYN="N">Quadrivalent meningococcal vaccine</Keyword><Keyword MajorTopicYN="N">Serum bactericidal activity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>06</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>08</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>08</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25152325</ArticleId><ArticleId IdType="pii">S0264-410X(14)01140-2</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2014.08.027</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000769 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000769 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:25152325
|texte= Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25152325" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |